University of Pittsburgh

Chenjie Yang, PhD

Technical Account Manager





	
	


			

		Dr. Chenjie Yang	
		

		

	
Contact

    	
		
	
	
	    

    
    
   
    
   
    
        
    
   
   
   
   
   
   
    
    
	
	
	
		
		
	



	
Education
	
	

	
PhD in Biochemistry and Molecular Genetics, University of Pittsburgh, School of Medicine, 2010
BS in Biology, Zhejiang University, Hangzhou (China), 2004
        

              
   
  
 
 


  
 
 
 
 
 	
Program
	
	

	Biochemistry and Molecular Genetics	
	


 
 
 	
Mentor
	
	

	
Paul D. Robbins, PhD
        

                
        
        
        
        	
Dissertation
	
	

	Characterization of Tumor-Derived Exosomes and Their Role in Immune Regulation.	
	


        
        
        
        
 
 
   
   
















        













	
Areas of Interest
	
	

	Immunoregulation by tumor-derived exosomes and plasma-derived exosomes; Characterization of exosomes released by senescence cells and stem cells	
	






	
Why I Chose Pitt
	
	

	
I came to Pitt because of the attractive Interdisciplinary Biomediacal Graduate Program. I was truely impressed by its outstanding faculty members and research environment during my Ph.D. study and I'm happy to extend my stay as a postdoc to further the research projects I'm interested in.
After her graduation, Chenjie received an offer to work under her mentor, Dr. Paul Robbins, as a Postdoctoral Associate. Dr. Yang currently works as a Technical Account Manager for GenScript USA Inc., in New Jersey.
Abstracts
Characterization of tumor-derived exosomes and their role in immunoregulation. 2009 FOCIS meeting, Poster of Distinction, San Francisco, June.
Development and use of FLAG-tag based system for detection and purification of exosomes. 2009 BMES Annual Meeting, Pittsburgh, October.
 
	
	




	
Publications
	
	

	
Plasma-derived MHC class II+ exosomes from tumorbearing mice suppress tumor antigen-specific immune responses. Eur J Immunol. 42: 1778-1784.  |  View Abstract
Exosomes released from mycoplasma infected tumor cells activate inhibitory B cells. PLoS One. 7: e36138. |  View Abstract
Immunosuppressive Exosomes: A New Approach for Treating Arthritis. Int J Rheum. Vol 2012, Article ID 573528, 8 pages. |  View Abstract
The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol. 2011: 842849. |  View Abstract
Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One. 6: e22517. |  View Abstract